Your supervisor provided some valuable feedback in response to your outline! They are excited to see the PowerPoint slideshow you are creating for your topic’s in-service training. Having developed a number of presentations for in-services, your supervisor offered the following advice:
“When developing a slideshow, it’s important to be mindful of how you layout your content. For an in-service presentation, the slides should present key points, be arranged logically, without extraneous information contributing to a cluttered look. The audience should get a lot of the content from listening to what you say, not just from reading the slides. Using the Speaker Notes feature in PowerPoint is a great way to include relevant details that you want to provide without overloading the slides.”
Your supervisor wants you to work from your outline and prepare a visually appealing PowerPoint slideshow for the in-service presentation. They said it should:
Have a title slide.
Contain 6-10 content slides pertaining to the important content areas for your presentation topic.
Use the Speaker Notes feature in PowerPoint to reduce the amount of text that appears on the slides. (The Speaker Notes will contain the text that will guide what you say while presenting the slides.)
Be written using proper spelling/grammar.
Cite at least 2 credible references and present the sources in APA format on a References slide.
Polypharmacy
Polypharmacy encompasses the use of a set
of various drugs/ medications on a single patient to treat several diseases.
This is due to multimorbidity, a state most noticeable in old people (Marengoni
et al., 2020). The understanding and explanation of polypharmacy are essential
in getting to decide how efficient certain drugs are when combined together. Old
people, most significantly, who are most vulnerable to suffering most lifestyle
conditions, tend to be the most affected by this understanding.
Detailed outline
I.
Occurrence of polypharmacy
A. Understanding polypharmacy. The various descriptions of polypharmacy
there exist are described.
B. Relationship between polypharmacy and multimorbidity. Multimorbidity
as a significant cause and contributor of polypharmacy is examined.
C. The various case-by-case research projects that have been done to be
able to analyze the occurrences of polypharmacy are analyzed.
Source: Morin and co-authors on the epidemiology of polypharmacy in older adults: register-based
prospective cohort study. Page 10, 289298
II.
Effects/ Disadvantages of
Polypharmacy
A.
The relationship between old
age and polypharmacy. The analysis as to why the old are most prevalent to
multimorbidity is discussed.
B.
Reasons as to why more research
needs to be done to better understand the effects of polypharmacy and
multimorbidity are discussed.
C.
The association between
polypharmacy and reduced life spans is analyzed. In addition, the reasons
behind limited lifespans among patients under polypharmaceutical treatment are
analyzed.
Source: Roughead and co-authors on
multimorbidity, care complexity, and prescribing for the elderly. Page 7(5),
695-705.
Conclusion
There is an upside and disadvantage to
virtually everything. It is essential to also consider the wishes of the
patients under polypharmaceutical treatment procedures. Many end up getting
hospitalized for extended periods. More research on the same is thus needed.
References
Morin, L., Johnell, K., Laroche, M. L., Fastbom, J., & Wastesson, J.
W. (2018). The epidemiology of polypharmacy in older adults: register-based
prospective cohort study. Clinical epidemiology, 10,
289298. https://doi.org/10.2147/CLEP.S153458
Roughead, E. E.,
Vitry, A. I., Caughey, G. E., & Gilbert, A. L. (2019).
Multimorbidity, care complexity, and prescribing for the elderly. Aging
Health, 7(5),
695-705. https://doi.org/10.2217/ahe.11.64
Last Completed Projects
| topic title | academic level | Writer | delivered |
|---|